Education
About Us
Working with TipRanks
Follow Us
Heather Preston Insider Profile
4 Followers
Heather Preston, Director at Oxford BioMedica, holds 29.69K shares in Oxford BioMedica (Ticker: OXBDF), holds 8.82K shares in Fusion Pharmaceuticals (Ticker: FUSN). Most recently, Heather Preston Bought ― shares of Oxford BioMedica on Jun 17, 2025 for an estimated value of 36.90K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-3.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Heather Preston's holdings
Insider Roles
Director
Roles that Heather Preston holds in companies
Most Profitable Insider Trade
The most profitable trade made by Heather Preston
Heather Preston's Trading History
Oxford BioMedica
Jun 17, 2025
Director
Informative Buy
36.90K
$157.04K
Fusion Pharmaceuticals
―
―
―
$190.14K
List of latest transactions for each holding click on a transaction to see Heather Preston's performance on stock
You May Also Like
Heather Preston insider profile FAQ
What is the percentage of profitable transactions made by Heather Preston?
The percentage of profitable transactions made by Heather Preston is 50%.
What is the average return per transaction made by Heather Preston?
The average return per transaction made by Heather Preston is -3.90%.
What stocks does Heather Preston hold?
Heather Preston holds: OXBDF, FUSN stocks.
What was Heather Preston’s latest transaction?
Heather Preston latest transaction was an Informative Buy of $36.90K.
What was Heather Preston's most profitable transaction?
Heather Preston’s most profitable transaction was an Informative Buy of OXBDF stock on June 17, 2025. The return on the trade was 17.10%.
What is Heather Preston's role in Oxford BioMedica?
Heather Preston's role in Oxford BioMedica is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.